Ruggeri, Matteo, Michele Basile, Alessandro Armuzzi, and Americo Cicchetti. “Activity-Based Costing and Budget Analysis of Vedolizumab Versus Conventional Treatments in Ulcerative Colitis and Crohn’s Disease: Analisi Organizzativa E Di Budget Dell’introduzione Di Vedolizumab Vs Terapie Tradizionali in Colite Ulcerosa E Morbo Di Crohn”. Global and Regional Health Technology Assessment 4, no. 1 (August 4, 2017): 88–99. Accessed November 21, 2024. https://journals.aboutscience.eu/index.php/grhta/article/view/382.